SCM
CCXI

Sio Capital Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Sio Capital Management’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-100,000
Closed -$930K – 92
2019
Q2 		$930K Buy
+100,000
New +$1.16M 0.22% 66

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sio Capital Management's CCXI Position: Q2 2019 in Review

Sio Capital Management sold out of ChemoCentryx, Inc. (CCXI) in Q2 2019, closing a stake of 530,175 shares — an estimated $6.14M sold.

Sio Capital Management first reported a position in CCXI in Q2 2016 and held it in 9 quarters. The position peaked at $7.36M in Q1 2019. 117 funds tracked by Wall St. Rank hold CCXI as of Q2 2019.

  • Sio Capital Management reported no remaining ChemoCentryx, Inc. position as of Q2 2019 after selling out during the quarter.
  • Sio Capital Management sold 530,175 ChemoCentryx, Inc. shares in Q2 2019, an estimated $6.14M.
  • Sio Capital Management first reported a position in ChemoCentryx, Inc. in Q2 2016 and held it in 9 quarters.
  • Sio Capital Management's ChemoCentryx, Inc. position peaked at $7.36M in Q1 2019.
  • 117 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2019.

Based on Sio Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.